Induced Pluripotent Stem Cells
"Induced Pluripotent Stem Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cells from adult organisms that have been reprogrammed into a pluripotential state similar to that of EMBRYONIC STEM CELLS.
| Descriptor ID |
D057026
|
| MeSH Number(s) |
A11.872.040.500 A11.872.700.500
|
| Concept/Terms |
Fibroblast-Derived Induced Pluripotent Stem Cells- Fibroblast-Derived Induced Pluripotent Stem Cells
- Fibroblast Derived Induced Pluripotent Stem Cells
- Fibroblast-Derived IPS Cells
- Cell, Fibroblast-Derived IPS
- Cells, Fibroblast-Derived IPS
- Fibroblast Derived IPS Cells
- Fibroblast-Derived IPS Cell
- IPS Cell, Fibroblast-Derived
- IPS Cells, Fibroblast-Derived
|
Below are MeSH descriptors whose meaning is more general than "Induced Pluripotent Stem Cells".
Below are MeSH descriptors whose meaning is more specific than "Induced Pluripotent Stem Cells".
This graph shows the total number of publications written about "Induced Pluripotent Stem Cells" by people in this website by year, and whether "Induced Pluripotent Stem Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 1 | 2 |
| 2014 | 0 | 2 | 2 |
| 2016 | 8 | 0 | 8 |
| 2017 | 30 | 17 | 47 |
| 2018 | 41 | 9 | 50 |
| 2019 | 10 | 5 | 15 |
| 2020 | 4 | 4 | 8 |
| 2021 | 7 | 3 | 10 |
To return to the timeline, click here.
Below are the most recent publications written about "Induced Pluripotent Stem Cells" by people in Profiles.
-
Comprehensive Cardiotoxicity Assessment of COVID-19 Treatments Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Toxicol Sci. 2021 08 30; 183(1):227-239.
-
Functional Characterization of Organoids Derived From Irreversibly Damaged Liver of Patients With NASH. Hepatology. 2021 10; 74(4):1825-1844.
-
COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab. PLoS One. 2021; 16(8):e0255976.
-
SARS-CoV-2 research using human pluripotent stem cells and organoids. Stem Cells Transl Med. 2021 11; 10(11):1491-1499.
-
Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models. mSphere. 2021 06 30; 6(3):e0027021.
-
SARS-CoV-2 infects an upper airway model derived from induced pluripotent stem cells. Stem Cells. 2021 10; 39(10):1310-1321.
-
Global virus tracker. Nature. 2021 05; 593(7857):160.
-
Human Pluripotent Stem Cell-Derived Intestinal Organoids Model SARS-CoV-2 Infection Revealing a Common Epithelial Inflammatory Response. Stem Cell Reports. 2021 04 13; 16(4):940-953.
-
iPSC screening for drug repurposing identifies anti-RNA virus agents modulating host cell susceptibility. FEBS Open Bio. 2021 05; 11(5):1452-1464.
-
Platforms for Personalized Polytherapeutics Discovery in COVID-19. J Mol Biol. 2021 05 14; 433(10):166945.